NOVARTIS AG-REG (1NOVN.MI) Stock Fundamental Analysis

BIT:1NOVN • CH0012005267

139 EUR
+4 (+2.96%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Taking everything into account, 1NOVN scores 6 out of 10 in our fundamental rating. 1NOVN was compared to 55 industry peers in the Pharmaceuticals industry. While 1NOVN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1NOVN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year 1NOVN was profitable.
  • In the past year 1NOVN had a positive cash flow from operations.
  • Each year in the past 5 years 1NOVN has been profitable.
  • Each year in the past 5 years 1NOVN had a positive operating cash flow.
1NOVN.MI Yearly Net Income VS EBIT VS OCF VS FCF1NOVN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • 1NOVN has a better Return On Assets (13.42%) than 85.45% of its industry peers.
  • With a decent Return On Equity value of 32.47%, 1NOVN is doing good in the industry, outperforming 76.36% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 18.48%, 1NOVN is doing good in the industry, outperforming 76.36% of the companies in the same industry.
  • 1NOVN had an Average Return On Invested Capital over the past 3 years of 12.05%. This is below the industry average of 14.21%.
  • The last Return On Invested Capital (18.48%) for 1NOVN is above the 3 year average (12.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.42%
ROE 32.47%
ROIC 18.48%
ROA(3y)10.82%
ROA(5y)11.4%
ROE(3y)23.55%
ROE(5y)24.08%
ROIC(3y)12.05%
ROIC(5y)10.61%
1NOVN.MI Yearly ROA, ROE, ROIC1NOVN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • The Profit Margin of 1NOVN (25.69%) is better than 83.64% of its industry peers.
  • 1NOVN's Profit Margin has been stable in the last couple of years.
  • With a decent Operating Margin value of 33.11%, 1NOVN is doing good in the industry, outperforming 76.36% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1NOVN has grown nicely.
  • 1NOVN has a Gross Margin of 76.10%. This is in the better half of the industry: 1NOVN outperforms 76.36% of its industry peers.
  • In the last couple of years the Gross Margin of 1NOVN has remained more or less at the same level.
Industry RankSector Rank
OM 33.11%
PM (TTM) 25.69%
GM 76.1%
OM growth 3Y8.17%
OM growth 5Y6.25%
PM growth 3Y-24.95%
PM growth 5Y-0.88%
GM growth 3Y0.5%
GM growth 5Y1.06%
1NOVN.MI Yearly Profit, Operating, Gross Margins1NOVN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1NOVN is creating value.
  • 1NOVN has less shares outstanding than it did 1 year ago.
  • 1NOVN has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for 1NOVN is higher compared to a year ago.
1NOVN.MI Yearly Shares Outstanding1NOVN.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
1NOVN.MI Yearly Total Debt VS Total Assets1NOVN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B

2.2 Solvency

  • 1NOVN has an Altman-Z score of 4.55. This indicates that 1NOVN is financially healthy and has little risk of bankruptcy at the moment.
  • With a Altman-Z score value of 4.55, 1NOVN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • 1NOVN has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1NOVN (1.87) is better than 89.09% of its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that 1NOVN is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.55, 1NOVN is doing good in the industry, outperforming 61.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.87
Altman-Z 4.55
ROIC/WACC3.74
WACC4.94%
1NOVN.MI Yearly LT Debt VS Equity VS FCF1NOVN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • 1NOVN has a Current Ratio of 0.88. This is a bad value and indicates that 1NOVN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1NOVN has a Current ratio of 0.88. This is amonst the worse of the industry: 1NOVN underperforms 81.82% of its industry peers.
  • A Quick Ratio of 0.68 indicates that 1NOVN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.68, 1NOVN is doing worse than 78.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.68
1NOVN.MI Yearly Current Assets VS Current Liabilites1NOVN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.33% over the past year.
  • 1NOVN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.14% yearly.
  • The Revenue has grown by 12.18% in the past year. This is quite good.
  • The Revenue has been growing slightly by 1.24% on average over the past years.
EPS 1Y (TTM)21.33%
EPS 3Y7.48%
EPS 5Y8.14%
EPS Q2Q%9.22%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y5.56%
Revenue growth 5Y1.24%
Sales Q2Q%5.6%

3.2 Future

  • 1NOVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
  • The Revenue is expected to grow by 5.27% on average over the next years.
EPS Next Y16.8%
EPS Next 2Y9.28%
EPS Next 3Y8.59%
EPS Next 5Y8.79%
Revenue Next Year9.91%
Revenue Next 2Y6.24%
Revenue Next 3Y5.54%
Revenue Next 5Y5.27%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1NOVN.MI Yearly Revenue VS Estimates1NOVN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
1NOVN.MI Yearly EPS VS Estimates1NOVN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 18.48, which indicates a rather expensive current valuation of 1NOVN.
  • Based on the Price/Earnings ratio, 1NOVN is valued a bit cheaper than the industry average as 61.82% of the companies are valued more expensively.
  • 1NOVN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 17.70, which indicates a rather expensive current valuation of 1NOVN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1NOVN indicates a somewhat cheap valuation: 1NOVN is cheaper than 65.45% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.96. 1NOVN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.48
Fwd PE 17.7
1NOVN.MI Price Earnings VS Forward Price Earnings1NOVN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 1NOVN's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, 1NOVN is valued a bit cheaper than the industry average as 76.36% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.56
EV/EBITDA 13.77
1NOVN.MI Per share data1NOVN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1NOVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.1
PEG (5Y)2.27
EPS Next 2Y9.28%
EPS Next 3Y8.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • 1NOVN has a Yearly Dividend Yield of 3.06%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.94, 1NOVN pays a bit more dividend than its industry peers.
  • 1NOVN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.79.
Industry RankSector Rank
Dividend Yield 3.06%

5.2 History

  • The dividend of 1NOVN has a limited annual growth rate of 5.49%.
Dividend Growth(5Y)5.49%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 1NOVN pays out 54.32% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • 1NOVN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP54.32%
EPS Next 2Y9.28%
EPS Next 3Y8.59%
1NOVN.MI Yearly Income VS Free CF VS Dividend1NOVN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
1NOVN.MI Dividend Payout.1NOVN.MI Dividend Payout, showing the Payout Ratio.1NOVN.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVARTIS AG-REG

BIT:1NOVN (2/13/2026, 7:00:00 PM)

139

+4 (+2.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-28
Earnings (Next)02-04
Inst Owners41.44%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap266.71B
Revenue(TTM)56.02B
Net Income(TTM)14.39B
Analysts71.25
Price Target117.29 (-15.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.06%
Yearly Dividend3.18
Dividend Growth(5Y)5.49%
DP54.32%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.75%
Min EPS beat(2)-2.1%
Max EPS beat(2)0.61%
EPS beat(4)3
Avg EPS beat(4)2.79%
Min EPS beat(4)-2.1%
Max EPS beat(4)6.59%
EPS beat(8)6
Avg EPS beat(8)2.02%
EPS beat(12)10
Avg EPS beat(12)3.45%
EPS beat(16)11
Avg EPS beat(16)2.48%
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-2.84%
Max Revenue beat(2)-2.82%
Revenue beat(4)1
Avg Revenue beat(4)-1.5%
Min Revenue beat(4)-2.84%
Max Revenue beat(4)0.78%
Revenue beat(8)4
Avg Revenue beat(8)-0.11%
Revenue beat(12)5
Avg Revenue beat(12)-3.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.77%
EPS NQ rev (1m)0.98%
EPS NQ rev (3m)-1.36%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 18.48
Fwd PE 17.7
P/S 5.65
P/FCF 18.56
P/OCF 15.03
P/B 7.14
P/tB N/A
EV/EBITDA 13.77
EPS(TTM)7.52
EY5.41%
EPS(NY)7.86
Fwd EY5.65%
FCF(TTM)7.49
FCFY5.39%
OCF(TTM)9.25
OCFY6.65%
SpS24.59
BVpS19.46
TBVpS-4.5
PEG (NY)1.1
PEG (5Y)2.27
Graham Number57.38
Profitability
Industry RankSector Rank
ROA 13.42%
ROE 32.47%
ROCE 24.64%
ROIC 18.48%
ROICexc 21.2%
ROICexgc 126.11%
OM 33.11%
PM (TTM) 25.69%
GM 76.1%
FCFM 30.45%
ROA(3y)10.82%
ROA(5y)11.4%
ROE(3y)23.55%
ROE(5y)24.08%
ROIC(3y)12.05%
ROIC(5y)10.61%
ROICexc(3y)14.73%
ROICexc(5y)13.01%
ROICexgc(3y)74.78%
ROICexgc(5y)64.95%
ROCE(3y)16.96%
ROCE(5y)14.93%
ROICexgc growth 3Y14.29%
ROICexgc growth 5Y25.26%
ROICexc growth 3Y20.9%
ROICexc growth 5Y13.17%
OM growth 3Y8.17%
OM growth 5Y6.25%
PM growth 3Y-24.95%
PM growth 5Y-0.88%
GM growth 3Y0.5%
GM growth 5Y1.06%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 1.87
Debt/EBITDA 1.01
Cap/Depr 74.31%
Cap/Sales 7.16%
Interest Coverage 18.85
Cash Conversion 87.98%
Profit Quality 118.52%
Current Ratio 0.88
Quick Ratio 0.68
Altman-Z 4.55
F-Score7
WACC4.94%
ROIC/WACC3.74
Cap/Depr(3y)51.13%
Cap/Depr(5y)48.4%
Cap/Sales(3y)6.48%
Cap/Sales(5y)6.27%
Profit Quality(3y)120.24%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)21.33%
EPS 3Y7.48%
EPS 5Y8.14%
EPS Q2Q%9.22%
EPS Next Y16.8%
EPS Next 2Y9.28%
EPS Next 3Y8.59%
EPS Next 5Y8.79%
Revenue 1Y (TTM)12.18%
Revenue growth 3Y5.56%
Revenue growth 5Y1.24%
Sales Q2Q%5.6%
Revenue Next Year9.91%
Revenue Next 2Y6.24%
Revenue Next 3Y5.54%
Revenue Next 5Y5.27%
EBIT growth 1Y21.58%
EBIT growth 3Y14.18%
EBIT growth 5Y7.57%
EBIT Next Year36.14%
EBIT Next 3Y13.19%
EBIT Next 5Y13.01%
FCF growth 1Y33.72%
FCF growth 3Y4.49%
FCF growth 5Y3.96%
OCF growth 1Y37.07%
OCF growth 3Y5.34%
OCF growth 5Y5.28%

NOVARTIS AG-REG / 1NOVN.MI FAQ

What is the ChartMill fundamental rating of NOVARTIS AG-REG (1NOVN.MI) stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1NOVN.MI.


What is the valuation status for 1NOVN stock?

ChartMill assigns a valuation rating of 5 / 10 to NOVARTIS AG-REG (1NOVN.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for NOVARTIS AG-REG?

NOVARTIS AG-REG (1NOVN.MI) has a profitability rating of 7 / 10.


What is the valuation of NOVARTIS AG-REG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NOVARTIS AG-REG (1NOVN.MI) is 18.48 and the Price/Book (PB) ratio is 7.14.


Is the dividend of NOVARTIS AG-REG sustainable?

The dividend rating of NOVARTIS AG-REG (1NOVN.MI) is 6 / 10 and the dividend payout ratio is 54.32%.